Scientists from Drexel University’s College of Medicine and Columbia University’s Irving Medical Center have uncovered a ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

Natural products derived from microorganisms are a promising source of new active ingredients, but are often produced only in ...

Scientists discovered a new class of antibiotic that kills bacteria in a unique way and isn't vulnerable to existing drug resistance. When you purchase through links on our site, we may earn an ...

In early July, the US Food and Drug Administration (FDA) approved a treatment called donanemab for people with early-stage Alzheimer’s disease. It is the second drug shown to slow the condition’s ...

Structure Therapeutics Inc. (NASDAQ:GPCR) was able to report positive results from its phase 2a study using its GLP-1R agonist GSBR-1290 for the treatment of patients with obesity in June 2024. This ...